Osmitrol (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Osmitrol drug offered from Baxter Healthcare Corporation. This Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | Mannitol |
SUBSTANCE NAME: | MANNITOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1964-06-08 |
END MARKETING DATE: | 0000-00-00 |
Osmitrol HUMAN PRESCRIPTION DRUG Details:
Item Description | Osmitrol from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(g/100mL) |
START MARKETING DATE: | 1964-06-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-0351_57c99c24-bbd8-4b9d-b29c-67e2c2d7a049 |
PRODUCT NDC: | 0338-0351 |
APPLICATION NUMBER: | NDA013684 |
Other MANNITOL Pharmaceutical Manufacturers / Labelers: